1. Home
  2. BNL vs NUVB Comparison

BNL vs NUVB Comparison

Compare BNL & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadstone Net Lease Inc.

BNL

Broadstone Net Lease Inc.

HOLD

Current Price

$18.64

Market Cap

3.3B

Sector

Real Estate

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$6.09

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNL
NUVB
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNL
NUVB
Price
$18.64
$6.09
Analyst Decision
Buy
Strong Buy
Analyst Count
8
9
Target Price
$19.75
$10.44
AVG Volume (30 Days)
1.9M
6.3M
Earning Date
02-18-2026
03-05-2026
Dividend Yield
6.21%
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$447,973,000.00
$26,748,000.00
Revenue This Year
$5.85
$616.63
Revenue Next Year
$7.00
$202.59
P/E Ratio
$39.81
N/A
Revenue Growth
5.49
1137.19
52 Week Low
$13.96
$1.54
52 Week High
$18.87
$9.75

Technical Indicators

Market Signals
Indicator
BNL
NUVB
Relative Strength Index (RSI) 67.39 31.51
Support Level $17.60 $5.60
Resistance Level $18.32 $6.63
Average True Range (ATR) 0.34 0.53
MACD 0.11 -0.35
Stochastic Oscillator 92.06 14.35

Price Performance

Historical Comparison
BNL
NUVB

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: